Tiny scope, big hope: new surgery aims to ease back pain without the usual side effects

NCT ID NCT07588555

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a new, smaller surgical tool called LUSE-TLIF against the current standard minimally invasive fusion (MIS-TLIF) for people with lumbar spinal stenosis. The new tool is a flexible endoscope only 1.8 mm wide, designed to give surgeons a better view and reduce muscle damage. Researchers will compare pain, disability, and bone fusion rates in 276 adults aged 40-70 over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
LUSE-TLIF (a new soft endoscope surgical procedure) compared to MIS-TLIF (standard minimally invasive surgery)
What this could lead to
If successful, this could offer a safer, more effective surgical option for lumbar spinal stenosis, potentially reducing chronic back pain and improving fusion rates.
What could go wrong
This is an early-stage, single-center trial with 276 participants. The new technique may not prove superior or could have unforeseen complications. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUMBAR SPINAL STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Third Affiliated Hospital of Southern Medical University

    RECRUITING

    Guangzhou, Guangdong, 515000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.